S 959
113th Congress
Senate
Health
Administrative law and regulatory procedures
Business records
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Federal preemption
Food and Drug Administration (FDA)
Licensing and registrations
Prescription drugs
Retail and wholesale trades
Small business
State and local government operations
User charges and fees
Veterinary medicine and animal diseases
Pharmaceutical Quality, Security, and Accountability Act
Introduced: May 15, 2013
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2013
Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.
Jun 19, 2013
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute and an amendment to the title. Without written report.
May 22, 2013
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 15, 2013
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 15, 2013
Introduced in Senate
Plain-English summary
Pharmaceutical Compounding Quality and Accountability Act - Sets forth provisions to revise the regulations regarding human compounding. Establishes requirements for animal drug compounding and biological product compounding. Requires the compounding manufacturers to: (1) register with the Secretary of Health and Human Services (HHS) annually, (2) report to the Secretary on the drugs it compounds, and (3) report serious adverse events associated with the use of compounded drugs. Requires the Secretary to assess establishment and reinspection fees.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.
Committees of jurisdiction
1
Cosponsors
1